Table 4.
Benefit-harm metric |
95% confidence interval* |
Probability of the metric being positive* |
||
---|---|---|---|---|
Main analysis | ||||
6 months | −129 | −242 to −14 | 1% | |
12 months | −317 | −436 to −196 | 0% | |
18 months | −390 | −514 to −264 | 0% | |
24 months | −526 | −687 to −368 | 0% | |
Sensitivity analysis one | ||||
6 months | −201 | −362 to −39 | 1% | |
12 months | −482 | −665 to −298 | 0% | |
18 months | −603 | −800 to −412 | 0% | |
24 months | −808 | −1049 to −570 | 0% | |
Sensitivity analysis two | ||||
6 months | −115 | −245 to 13 | 4% | |
12 months | −292 | −421 to −161 | 0% | |
18 months | −339 | −467 to −209 | 0% | |
24 months | −439 | −588 to −294 | 0% |
95% confidence interval and the probability of the metric being positive were calculated based on the 10000 bootstrapping replicates.